The Effects of the Diterpenes Isolated from the Brazilian Brown Algae Dictyota pfaffii and Dictyota menstrualis against the Herpes Simplex Type-1 Replicative Cycle

被引:58
作者
Abrantes, Juliana L.
Barbosa, Jussara
Cavalcanti, Diana
Pereira, Renato C.
Fontes, Carlos Frederico L.
Teixeira, Valeria L.
Souza, Thiago Moreno L.
Paixao, Izabel C. P.
机构
[1] Univ Fed Rio de Janeiro, Inst Bioquim Med, Lab Estrutura Regulacao Prot, Programa Posgrad Quim Biol, Rio De Janeiro, Brazil
[2] Univ Fed Fluminense, Inst Biol, Dept Biol Marinha, Niteroi, RJ, Brazil
[3] Univ Fed Fluminense, Inst Biol, Mol Virol Lab, Dept Bio Celular & Mol,Programa Posgrad Neuroimun, Niteroi, RJ, Brazil
[4] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Virus Resp & Sarampo, Lab Referencia Influenza & Viroses Exantemat, Rio De Janeiro, Brazil
关键词
Dictyotaceae; Dictyota menstrualis; Dictyota pfaffii; marine algae; diterpenes; antiviral; HSV-1; DOLABELLANE DITERPENE; NATURAL-PRODUCTS; VIRUS; PROTEIN; HSV-1; DRUGS; CELLS;
D O I
10.1055/s-0029-1186144
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
We describe in this paper that the diterpenes 8,10,18-trihydroxy-2,6-dolabelladiene ( 1) and (6R)-6-hydroxydichotoma-4,14-diene-1,17-dial (2), isolated from the marine algae Dictyota pfaffii and D. menstrualis, respectively, inhibited HSV-1 infection in Vero cells. We initially observed that compounds 1 and 2 inhibited HSV-1 replication in a dose-dependent manner, resulting in EC50 values of 5.10 and 5.90 mu M, respectively, for a multiplicity of infection (MOI) of 5. Moreover, the concentration required to inhibit HSV-1 replication was not cytotoxic, resulting in good selective index (SI) values. Next, we found that compound 1 sustained its anti-herpetic activity even when added to HSV-1-infected cells at 6 h after infection, while compound 2 sustained its activity for up to 3 h after infection, suggesting that these compounds inhibit initial events during HSV-1 replication. We also observed that both compounds were incapable of impairing HSV-1 adsorption and penetration. In addition, the tested molecules could decrease the contents of some HSV-1 early proteins, such as UL-8, RL-1, UL-12, UL-30 and UL-9. Our results suggest that the structures of compounds 1 and 2, Brazilian brown algae diterpenes, might be promising for future antiviral design.
引用
收藏
页码:339 / 344
页数:6
相关论文
共 35 条
[1]   New antiviral agents [J].
Nahed Abdel-Haq ;
Pimpanada Chearskul ;
Hossam Al-Tatari ;
Basim Asmar .
The Indian Journal of Pediatrics, 2006, 73 (4) :313-321
[2]   In vitro antiviral diterpenes from the Brazilian brown alga Dictyota pfaffii [J].
Barbosa, JP ;
Pereira, RC ;
Abrantes, JL ;
dos Santos, CCC ;
Rebello, MA ;
Frugulhetti, ICDP ;
Teixeira, VL .
PLANTA MEDICA, 2004, 70 (09) :856-860
[3]   A dolabellane diterpene from the Brazilian brown alga Dictyota pfaffii [J].
Barbosa, JP ;
Teixeira, VL ;
Villaça, R ;
Pereira, RC ;
Abrantes, JL ;
Frugulhetti, ICPD .
BIOCHEMICAL SYSTEMATICS AND ECOLOGY, 2003, 31 (12) :1451-1453
[4]  
Bastow K. F., 2004, Current Drug Targets - Infectious Disorders, V4, P323, DOI 10.2174/1568005043340533
[5]   Herpes simplex virus glycoprotein B binds to cell surfaces independently of heparan sulfate and blocks virus entry [J].
Bender, FC ;
Whitbeck, JC ;
Lou, H ;
Cohen, GH ;
Eisenberg, RJ .
JOURNAL OF VIROLOGY, 2005, 79 (18) :11588-11597
[6]   Inhibition of HIV-1 replication in human primary cells by a dolabellane diterpene isolated from the marine algae Dictyota pfaffii [J].
Cirne-Santos, CC ;
Teixeira, VL ;
Castello-Branco, LR ;
Frugulhetti, ICPP ;
Bou-Habib, DC .
PLANTA MEDICA, 2006, 72 (04) :295-299
[7]   The dolabellane diterpene Dolabelladienetriol is a typical noncompetitive inhibitor of HIV-1 reverse transcriptase enzyme [J].
Cirne-Santos, Claudio Cesar ;
Souza, Thiago Moreno L. ;
Teixeira, Valeria L. ;
Fontes, Carlos Frederico L. ;
Rebello, Moacyr A. ;
Castello-Branco, Luiz Roberto R. ;
Abreu, Celina M. ;
Tanuri, Amilcar ;
Frugulhetti, Izabel C. P. P. ;
Bou-Habib, Dumith Chequer .
ANTIVIRAL RESEARCH, 2008, 77 (01) :64-71
[8]  
De Clercq E, 2000, MED RES REV, V20, P323, DOI 10.1002/1098-1128(200009)20:5<323::AID-MED1>3.0.CO
[9]  
2-A
[10]  
De Clercq E, 2004, J CLIN VIROL, V30, P115, DOI [10.1016/j.jcv.2004.02.009, 10.1002/rmv.439]